DRAFT Innovative Solutions Opening ARPA-H PROactive Solutions for Prolonging Resilience (PROSPR)
ID: ARPA-H-SOL-25-125Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Bethesda, MD, 208920004, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)
Timeline
  1. 1
    Posted Dec 23, 2024, 12:00 AM UTC
  2. 2
    Updated Apr 22, 2025, 12:00 AM UTC
  3. 3
    Due Apr 25, 2025, 6:00 PM UTC
Description

The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the PROactive Solutions for Prolonging Resilience (PROSPR) program, aimed at extending the healthspan of Americans by 20 years. This initiative invites eligible applicants to develop innovative interventions focused on early disease prevention and addressing age-related health decline, which significantly impacts healthcare costs. The program encompasses three Technical Areas: developing a precise intrinsic capacity score for health predictions, repurposing FDA-approved drugs to enhance healthspan, and testing second-generation healthspan interventions through clinical trials. Interested parties can find more information and submit inquiries to the PROSPR Team at PROSPR@arpa-h.gov, with proposals due by the specified deadlines outlined in the solicitation documents.

Point(s) of Contact
PROSPR Email Box
PROSPR@arpa-h.gov
Files
Title
Posted
Apr 4, 2025, 7:08 PM UTC
The document outlines the ARPA-H solicitation for the PROactive Solutions for Prolonging Resilience (PROSPR) program, aimed at extending the healthspan of Americans by developing interventions that target the underlying causes of age-related health decline. The program includes establishing a predictive Intrinsic Capacity (IC) score, repurposing FDA-approved drugs, and testing second-generation interventions. The structured approach spans multiple technical areas over a five-year timeline, each with specific objectives, metrics, and phases, and engaging multidisciplinary teams to encourage collaboration. Key milestones include developing in-home assessment technologies, conducting decentralized clinical trials, and ensuring accessibility in health interventions. The program's ultimate goal is to create innovative preventative care models that reduce healthcare costs associated with chronic diseases while improving overall well-being for aging populations. Interested proposers are encouraged to attend a Proposers’ Day and submit questions via designated channels to promote participation and engagement.
Apr 4, 2025, 9:04 PM UTC
The Advanced Research Projects Agency for Health (ARPA-H) has issued a final Innovative Solutions Opening (ISO) titled "PROactive Solutions for Preserving Resilience" (PROSPR). The program aims to extend the healthspan of Americans by developing preventative interventions targeting the underlying causes of age-related health decline. Proposals are sought from eligible entities to negotiate multiple Other Transaction Agreements (OTs). The solicitation covers detailed program information, eligibility, submission, evaluation processes, and general requirements for proposers. The PROSPR program has a five-year scope and focuses on three technical areas: 1) development of an intrinsic capacity score to evaluate health outcomes, 2) repurposing FDA-approved interventions, and 3) creating second-generation interventions. Each area includes defined phases for development, trials, and metrics to measure progress. The program aims to transform geriatric medicine into a preventive care model, emphasizing accessibility and health equity. With a variety of innovative deliverables and collaborative approaches, PROSPR seeks to tackle the significant economic burden of chronic diseases and enhance proactive health management for aging populations. Key deadlines for submission are set for April and May 2025, and interested proposers can find more information on the ARPA-H website.
Apr 22, 2025, 7:06 PM UTC
The Advanced Research Projects Agency for Health (ARPA-H) launched the PROactive Solutions for Preserving Resilience (PROSPR) program through the Innovative Solutions Opening (ISO), aiming to extend Americans' healthspan by 20 years. This five-year initiative invites eligible applicants to propose interventions that focus on early disease prevention, targeting age-related health decline, which significantly affects healthcare costs. The program comprises three Technical Areas (TAs): 1. **TA1** focuses on developing a precise intrinsic capacity (IC) score to predict long-term health outcomes and creating an in-home assessment technology for continuous health monitoring. 2. **TA2** emphasizes the identification and repurposing of FDA-approved drugs to enhance healthspan, incorporating biomarkers from clinical trials to validate the effectiveness of these interventions. 3. **TA3** aims to test second-generation healthspan interventions through preclinical and first-in-human trials to evaluate safety and effectiveness. Proposers must ensure accessibility and inclusivity in their solutions, with a strong emphasis on regulatory compliance and collaboration across teams. The ISO timeline outlines key milestones, requiring participants to submit proposals by set deadlines and engage with regulatory bodies to establish innovative health interventions effectively.
Apr 22, 2025, 7:06 PM UTC
The ARPA-H Model Other Transaction Agreement pertains to the PROactive Solutions for Prolonging Resilience (PROSPR) program, which aims to develop interventions to extend healthspan by 20 years, addressing age-related health loss. The sample agreement outlines the terms and conditions for federal funding and project execution details, including project duration, management structure, deliverables, and financial obligations. Key components include the expectation for the Performer to manage the project, report milestones, and ensure compliance with regulations, particularly regarding human subjects and intellectual property rights. The agreement also details the Government's rights over inventions and data generated, emphasizing a collaborative approach while allowing flexibility for modifications. Lastly, the document emphasizes the importance of protecting intellectual property, especially regarding foreign access and security. This agreement serves as a framework for expedited negotiations for potential project awards, ensuring clarity in roles, responsibilities, and expected outcomes in advancing aging-related health interventions within a structured federal funding context.
Apr 22, 2025, 7:06 PM UTC
The document outlines a federal government Request for Proposal (RFP) focused on cost proposal submissions by potential contractors. Its primary purpose is to guide proposers in developing, structuring, and providing thorough cost proposals that will be assessed by government officials during the evaluation process. Key elements include a detailed breakdown of projected costs, such as direct labor, general and administrative (G&A), subcontractors, consultants, and other direct costs. The document stresses the importance of justifying cost estimates and requires proposers to offer a clear explanation and evidence supporting their suggested expenses. Proposers must complete various tabs in the provided spreadsheet for different periods, including cost summaries for each task in the statement of work, ensuring that all expenses align with the total amounts submitted. Furthermore, the document emphasizes that all cost entries need to be precise and reconciled across worksheets to facilitate a streamlined evaluation and negotiation if selected for contract award. Important considerations such as fiscal year definitions and applicable labor categories are also outlined, highlighting the significance of adhering to federal guidelines and standards in proposal submissions. Overall, the document serves as a comprehensive guide enhancing transparency and consistency in the RFP process.
Lifecycle
Title
Type
Similar Opportunities
Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.
Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.
Pharmacogenomics (PGx) Testing for Military Readiness Pilot
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for a pilot program focused on pharmacogenomics (PGx) testing to enhance military readiness and healthcare delivery for Active-Duty service members. The initiative aims to establish standardized processes for routine PGx testing within the Military Health System (MHS), leveraging electronic health record (EHR) data to improve clinical decision-making and treatment outcomes. This program is critical for optimizing medication safety and efficacy, ultimately preventing adverse drug reactions and improving overall health conditions for military personnel. Interested parties should contact Dr. Lauren Palestrini at lauren.palestrini@mtec-sc.org, with a funding availability of $2.2 million and a project duration of up to 36 months. The Request for Project Proposals (RPP) is expected to be released soon, with a proposal preparation period of approximately 30 days.
RRPV Solicitation Summary: Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is seeking proposals for the establishment of a Central Influenza and Emerging Infectious Diseases Vaccine Immunoassay Laboratory. This initiative aims to enhance national health security by facilitating the rapid development of vaccines in response to potential pandemics, with a focus on conducting immunoassays to support vaccine research and clinical trials. The successful offeror will play a critical role in strengthening biodefense infrastructure by providing standardized laboratory services, with proposals due by May 30, 2025, and questions accepted until April 24, 2025. Interested parties can contact Rebecca Harmon at rebecca.harmon@ati.org for further information.
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
Buyer not available
Special Notice DEPT OF DEFENSE is seeking proposals for extramural biomedical research and development. This opportunity is issued by the DEFENSE HEALTH AGENCY (DHA) under the BROAD AGENCY ANNOUNCEMENT (BAA) HT9425-23-S-SOC1. The purpose of this BAA is to solicit research and development ideas to advance the state-of-the-art or increase knowledge in the field. The projects funded under this BAA should focus on basic and applied research rather than the development of specific systems or hardware solutions. The research and development funding is expected to benefit both military and civilian medical practice and knowledge. Interested parties must submit a pre-proposal through the electronic Biomedical Research Application Portal (eBRAP). If selected, the offeror will be invited to submit a full proposal or application through Grants.gov. The BAA is open for a 5-year period, from August 1, 2023, to July 31, 2028. The BAA with revised research areas of interest and General Submission Instructions can be found on Grants.gov using opportunity number HT9425-23-S-SOC1.
Reengineering Enabling Sleep Transitions in Operationally Restrictive Environments (RESTORE)
Buyer not available
The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals for the Reengineering Enabling Sleep Transitions in Operationally Restrictive Environments (RESTORE) program, aimed at enhancing sleep efficiency and cognitive performance under sleep-restricted conditions. The program seeks to develop multimodal, multitarget, noninvasive neuromodulation methods to repair disrupted sleep architectures, specifically targeting improvements in cognitive metrics such as attention and processing speeds by at least 25%. This initiative is critical for addressing the challenges faced by military personnel in operational environments where sleep deprivation is prevalent. Interested parties should submit their proposals in compliance with the outlined guidelines, with the primary contact for inquiries being the BAA Coordinator at RESTORE@darpa.mil. The program anticipates multiple awards and emphasizes the importance of regulatory compliance and ethical standards in human subjects research.
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 for advanced research and development of Medical Countermeasures (MCMs) aimed at addressing public health threats such as chemical, biological, radiological, and nuclear (CBRN) incidents, as well as emerging infectious diseases and pandemic influenza. The initiative seeks to foster public-private partnerships to enhance the development and responsiveness of life-saving MCMs, emphasizing the importance of technological maturity, regulatory compliance, and manufacturing standards in the evaluation process. This opportunity is critical for strengthening national health security and improving preparedness for future public health emergencies, with an open submission period running until September 25, 2028, at 4:30 PM Eastern Time. Interested parties can direct inquiries to BARDA-BAA@hhs.gov for further information.
Remote Health Readiness Program 4 (RHRP-4)
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), is soliciting proposals for the Remote Health Readiness Program 4 (RHRP-4), aimed at providing comprehensive medical and dental readiness services to military personnel, including active and reserve components, as well as Department of Homeland Security members. The contract, structured as an Indefinite Delivery Indefinite Quantity (IDIQ) agreement, will span ten years and is valued at a maximum of $1.61 billion, focusing on maintaining the health and readiness of service members through various assessments, treatments, and logistical support. This initiative underscores the importance of ensuring a medically ready force, with contractors required to establish a network of certified providers and adhere to strict quality control and reporting standards. Interested parties must submit their proposals by May 9, 2025, and can direct inquiries to Nakaura C. Yusuf at nakaura.c.yusuf.civ@health.mil or by phone at 703-681-5821.